Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


LipiFlow®: Advanced Procedure to Treat Meibomian Gland Dysfunction & Chronic Dry Eye


 

Dry eye is one of the most common reasons people seek care from an eye doctor. Symptoms include a gritty sensation, watering, redness, and fluctuation in vision.

Dry eye often results in a cascade of inflammation affecting the surface of the eye, which can lead to potential damage including scarring and loss of vision clarity if uncontrolled over time. One of the most pressing modern risk factors for dry eye is increased time using digital devices, often starting in early childhood. Blinking is essential to spread tears evenly over the surface and promote normal eyelid gland function. Yet, the blink rate has shown to be significantly reduced during the use of digital screens.

A landmark 2012 study showed that 86 percent of patients with dry eye have concurrent meibomian gland dysfunction. The meibomian glands line the upper and lower eyelids. Healthy glands produce a free-flowing, oily, lipid solution that helps to prevent tears from evaporating. Over time in just about everyone, the glands start to produce very thick secretions and become backed up and clogged. This prevents the release of the solution which, in turn, causes tears to evaporate too quickly, leading to dry eye. If the blockage persists for too long, the glands start to function poorly and eventually start to drop out altogether, leading to a complete loss of secretion. Once gland loss occurs, it is believed to be irreversible.

The LipiView® and LipiScanTM devices from Johnson & Johnson are advanced technologies to image these glands. This safe, non-invasive technology has recently become available to eye doctors and is similar to how a dentist uses X-rays to image the deeper structure of teeth. High definition imaging of the glands in the eyelid can determine if they are functioning properly or if loss is starting to occur. This loss can lead to a cycle of worse dry eye and worse symptoms. Fortunately, if treatment is initiated, the meibomian glands can be kept flowing properly, thus promoting improved comfort and long-term function.

Traditional treatments for meibomian gland dysfunction include home therapies to warm the glands. Patients can use warm washcloths or store-bought masks that are designed to heat the glands followed by gentle eyelid massage. The difficulty is that the glands line the inner surface of the eyelids, so adequate heat must be applied to travel through the skin and reach the glands. Commonly, patients do not use enough heat and therefore the compresses are less effective. However, patients many see improvements in treatment of the condition if they are diligent about keeping up with these compresses each and every day.

A sophisticated and FDA-approved treatment for meibomian gland dysfunction can be administered in the office of an eye doctor in a single session. The LipiFlow® Thermal Pulsation System by Johnson & Johnson has several significant advantages to traditional home treatments. Foremost, the glands are heated from the inside, where they can be most effectively reached. This brings the secretions inside the gland to a temperature that causes them to flow freely, like melting candle wax. A precise, gentle pressure is applied to the eyelids throughout the procedure to help improve the gland output.

The treatment takes 12 minutes, is noninvasive and pain free. Small applicators are placed under the eyelids, comfortably vaulting over the delicate structures of the eye surface. Most patients report the procedure is a spa-like experience for the eyes, much like a gentle massage. Patients can resume all normal activities immediately following the treatment. For many, relief of symptoms is realized within days. Furthermore, the procedure promotes the glands of the eyelids to stay free-flowing and form healthy secretions, which prevents loss of function of the glands. In-office treatments have beneficial effects that can last up to one to two years and might be extended further with diligent home therapy afterwards.

These advancements in imaging and treatment provide a sophisticated way to promote good eyelid health and improve dry eye symptoms in the short and long term. The procedure is not covered by insurance, but patients generally feel the cost is worthwhile given the benefits in symptoms they experience after treatment.


Harvard & MIT graduate (MD, magna cum laude) Ming Wang, MD, PhD, is the CEO of Aier-USA and director of Wang Vision 3D Cataract & LASIK Center. One of the few laser eye surgeons who hold a doctorate degree in laser physics, Wang has published nine textbooks, holds several U.S. patents and performed the world's first laser artificial cornea implantation. He is also founder of a 501c(3) nonprofit charity that provides sight restoration surgeries for indigent patients. Wang Vision offers both the gland imaging and LipiFlow® technology described above to new and existing dry eye patients. For more information, go online to wangcataractLASIK.com or email drwang@wangvisioninstitute.com.




WEB:

Wang Vision

LipiFlow

 
Share:

Related Articles:


Recent Articles

AHA's Maryjane Wurth To Retire In 2020; Michelle Hood To Join The Association

Maryjane Wurth, the American Hospital Association's (AHA) executive vice president and chief operating officer (COO), will retire next year after a long and distinguished career in the hospital association field.

Read More

Tennessee Sees Fewer Infant Deaths In 2018

Infant Mortality Data Dashboard Now Available

Read More

Amedisys Expanding Commitment to End-of-Life Care for Veterans

Third Largest Hospice Provider Cared for 5,540 Dying Veterans Last Year

Read More

AMA Applauds Relief from Documentation Burden in New Medicare Rule

Many physicians will have reduced documentation beginning in 2021

Read More

Oncology Innovation in Nashville

From personalized medicine to innovation in GI care, Middle Tennessee oncology leaders share promising news.

Read More

Critical Insights into Nashville Health

For the first time in nearly two decades, Nashville has a countywide assessment providing insights into the health and well-being of the community.

Read More

Physician Spotlight: Leading with Compassion

Hospice care is so much more than simply pain management. Compassus CMO Dr. Kurt Merkelz focuses on helping patients live fully until the end.

Read More

The Oncology Care Model Value Proposition

The American Journal of Managed Care® hosts meetings across the country to help oncology practices understand and navigate the value-based care landscape at the intersection of quality and efficiency.

Read More

Tennessee Falling Short on Cancer-Fighting Public Policies

A 2019 ACS CAN report shows the state is falling short on public policies to fight cancer.

Read More

ONcology Rounds

Middle Tennessee's robust oncology programs are tackling cancer on numerous fronts.

Read More

Email Print
 
 

 

 


Tags:
Chronic Dry Eye, Meibomian Gland Dysfunction, Ming Wang
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: